MULTIPLE MYLEOMA
Clinical trials for MULTIPLE MYLEOMA explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYLEOMA trials appear
Sign up with your email to follow new studies for MULTIPLE MYLEOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Universal 'Off-the-Shelf' cell therapy tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis early-phase study is testing a new type of cell therapy called UWD-00B for people with multiple myeloma that has come back or stopped responding to standard treatments. The therapy uses genetically modified immune cells designed to target and attack the cancer. Researchers a…
Matched conditions: MULTIPLE MYLEOMA
Phase: EARLY_PHASE1 • Sponsor: Wondercel Biotech (ShenZhen) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New shot aims to shield cancer patients from dangerous infections
Prevention Recruiting nowThis study is testing whether adding an antibody-boosting medication called Xembify to standard care can help prevent serious bacterial infections in adults with certain blood cancers. Participants must have low antibody levels and a history of severe or frequent infections. The …
Matched conditions: MULTIPLE MYLEOMA
Phase: PHASE3 • Sponsor: Grifols Therapeutics LLC • Aim: Prevention
Last updated Mar 30, 2026 14:35 UTC